Vaishali Pharma Limited

Healthcare

NSE: VAISHALI
₹8.35
▼ -0.04 (-0.48%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
50/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
13.9
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-0 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

0 of 1 met
  • No Promoter holding rose or was unchanged in the latest quarter

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 8.3100 · High 8.9900
1W return
-1.2%
Low 8.3100 · High 8.9900
1M return
3.6%
Low 7.8100 · High 9.4200
52W return
-27.0%
Low 4.7500 · High 11.8800
Lifetime High ₹212.8500 (Oct. 11, 2024)
Lifetime Low ₹4.8800 (March 30, 2026)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
8.4
10D
8.5
20D
8.4
50D
8.2
100D
8.0
200D
7.7

Delivery and volume

Day avg. delivery
80.7%
Week avg. delivery
77.6%
Month avg. delivery
70.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

8.55
Pivot
First resistance8.79
Second resistance9.23
Third resistance9.47
First support8.11
Second support7.87
Third support7.43
Day RSI48.8
Day MFI56.6
Day MACD0.08
Day MACD signal0.12

Beta

1M-0.60
3M0.24
1Y1.06
3Y0.88

Price change analysis

↑ 3.6%
Over 1 Month
LowHigh
7.819.42
↑ 12.7%
Over 3 Months
LowHigh
6.969.42
↑ 42.7%
Over 6 Months
LowHigh
5.329.42
↓ -27.0%
Over 1 Year
LowHigh
4.7511.88
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹23 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jul 2026
  • Promoter30.54%

Largest holders

NameCategoryShares %Shares
ATUL ARVINDBHAI VASANIPromoter23.0700%31140230
SAPAN ANIL SHAHPublic6.1700%8325921
JAGRUTI ATUL VASANIPromoter5.0400%6799920
Kesar Pharma LimitedPublic3.3600%4537865
NUPUR ANIL SHAHPublic3.1600%4272592

As of July 3, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 31.61% to 30.54% in Jul 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 7 insider trades, 13 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
11 Jun 2024 JAGRUTI ATUL VASANI Promoter Buy 0 ₹0
23 Mar 2022 ATUL ARVIND VASANI Promoter group Sell 0 ₹0
15 Mar 2022 Atul Arvind Vasani Promoter group Sell 0 ₹0
11 Feb 2022 Atul Vasani Promoter Sell 0 ₹0
8 Feb 2022 BHARTI KIRITKUMAR TOLIA Promoter group Buy 0 ₹0
8 Feb 2022 BHARTI KIRITKUMAR TOLIA Promoter Buy 0 ₹0
22 Jul 2019 Atul Vasani Promoter Sell 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
7 Oct 2025 SHAH NISHANT Bulk Sell 587,125 11.2400 NSE
6 Aug 2025 SHALIN MAHESHBHAI SHAH Bulk Sell 642,206 12.9400 NSE
15 Jul 2025 KABRA PRIYA Bulk Buy 558,549 12.5500 NSE
24 Jun 2025 SHAH NISHANT Bulk Buy 750,000 12.4600 NSE
12 May 2025 NISHANT PITTI Bulk Sell 741,798 12.0300 NSE
9 May 2025 NISHANT PITTI Bulk Sell 586,452 11.1800 NSE
8 May 2025 NISHANT PITTI Bulk Buy 591,452 12.3200 NSE
8 May 2025 NISHANT PITTI Bulk Sell 5,000 12.5100 NSE
2 May 2025 NISHANT PITTI Bulk Sell 1,545,419 13.0800 NSE
15 Oct 2024 SHAH NISHANT Bulk Buy 462,290 24.8800 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results/Other business matters Yes
8 Jul 2026 Fund Raising —
2 Jul 2026 Fund Raising/Other business matters —
30 May 2026 Financial Results/Other business matters Yes
13 Feb 2026 Financial Results/Other business matters Yes

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 27.0% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Vaishali Pharma Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.